A Phase Ib/II Study to Evaluate the Safety, Feasibility and Efficacy of Nivolumab or Nivolumab in Combination with 5-Azacytidine in Patients with Recurrent, Resectable Osteosarcoma
Clinical Trial Grant
Administered By
Pediatrics, Hematology-Oncology
Awarded By
H. Lee Moffitt Cancer Center & Research Institute
Start Date
February 26, 2021
End Date
June 30, 2023
Administered By
Pediatrics, Hematology-Oncology
Awarded By
H. Lee Moffitt Cancer Center & Research Institute
Start Date
February 26, 2021
End Date
June 30, 2023